Angiodroid S.p.A.

About Angiodroid S.p.A.

Angiodroid is a healthcare company focused on revolutionizing angiographic exams through innovative Carbon Dioxide Angiography technology. Their mission is to reach patients worldwide quickly, preserve renal function, save lives, and improve the quality of life through constant innovation.

Products & Services

CO₂ Injector:A device for automated carbon dioxide angiography used in peripheral diagnostic and interventional procedures.

Disposables:Includes the Single Use Adaptor and Procedural Kit for use with the CO₂ Injector.

Angiopulse:A product related to Angiodroid's angiography solutions (specific details not provided).

Specialties

Carbon Dioxide Angiography Peripheral Diagnostic and Interventional Procedures Renal Function Preservation Medical Imaging Innovation

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 7000000 MR: - FA: €7 million FAN: 7000000	D: 2023-02-27 FD: 2023-02-27	3 investors

Series A Latest

2023-02-27

$7.0M

3 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

M

Michael Jackson

Recent News

Angiodroid S.p.A. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised